AbbVie Inc. (ABBV) operating KPIs

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value

$294.89+4.10 (+1.41%)

Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%

AbbVie weighted-average diluted shares outstanding (M)

Form 10-Q / 10-K

Quarterly Annual

Latest, Q2 2026

1,771.00

Period ended Jun 30, 2026

Change on a year earlier

0.0%

1,771.00 in Q2 2025

History

44 quarters

Since Q1 2012

Sources

Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

Period	Ended	Weighted-average diluted shares outstanding (M)	Year on year	Source
Q2 2026	Jun 30, 2026	1,771.00	0.0%	Form 10-Q (filed 2026-08-03) ↗
Q1 2026	Mar 31, 2026	1,774.00	+0.1%	Form 10-Q (filed 2026-05-08) ↗
Q3 2025	Sep 30, 2025	1,772.00	0.0%	Form 10-Q (filed 2025-11-04) ↗
Q2 2025	Jun 30, 2025	1,771.00	0.0%	Form 10-Q (filed 2025-08-04) ↗
Q1 2025	Mar 31, 2025	1,772.00	-0.1%	Form 10-Q (filed 2025-05-09) ↗
Q3 2024	Sep 30, 2024	1,772.00	+0.1%	Form 10-Q (filed 2024-11-04) ↗
Q2 2024	Jun 30, 2024	1,771.00	0.0%	Form 10-Q (filed 2024-08-07) ↗
Q1 2024	Mar 31, 2024	1,773.00	-0.2%	Form 10-Q (filed 2024-05-03) ↗
Q3 2023	Sep 30, 2023	1,771.00	-0.3%	Form 10-Q (filed 2023-11-06) ↗
Q2 2023	Jun 30, 2023	1,771.00	-0.3%	Form 10-Q (filed 2023-08-07) ↗
Q1 2023	Mar 31, 2023	1,776.00	-0.1%	Form 10-Q (filed 2023-05-05) ↗
Q3 2022	Sep 30, 2022	1,776.00	-0.1%	Form 10-Q (filed 2022-11-04) ↗
Q2 2022	Jun 30, 2022	1,776.00	0.0%	Form 10-Q (filed 2022-08-04) ↗
Q1 2022	Mar 31, 2022	1,778.00	+0.2%	Form 10-Q (filed 2022-05-06) ↗
Q3 2021	Sep 30, 2021	1,777.00	+0.2%	Form 10-Q (filed 2021-11-02) ↗
Q2 2021	Jun 30, 2021	1,776.00	+7.8%	Form 10-Q (filed 2021-08-02) ↗
Q1 2021	Mar 31, 2021	1,775.00	+19.6%	Form 10-Q (filed 2021-05-07) ↗
Q3 2020	Sep 30, 2020	1,774.00	+19.6%	Form 10-Q (filed 2020-11-04) ↗
Q2 2020	Jun 30, 2020	1,647.00	+11.0%	Form 10-Q (filed 2020-08-04) ↗
Q1 2020	Mar 31, 2020	1,484.00	+0.1%	Form 10-Q (filed 2020-05-08) ↗
Q3 2019	Sep 30, 2019	1,483.00	-2.1%	Form 10-Q (filed 2019-11-06) ↗
Q2 2019	Jun 30, 2019	1,484.00	-5.6%	Form 10-Q (filed 2019-08-05) ↗
Q1 2019	Mar 31, 2019	1,483.00	-7.1%	Form 10-Q (filed 2019-05-03) ↗
Q3 2018	Sep 30, 2018	1,515.00	-5.5%	Form 10-Q (filed 2018-11-07) ↗
Q2 2018	Jun 30, 2018	1,572.00	-1.7%	Form 10-Q (filed 2018-08-07) ↗
Q1 2018	Mar 31, 2018	1,596.00	-0.4%	Form 10-Q (filed 2018-05-04) ↗
Q3 2017	Sep 30, 2017	1,603.00	-2.3%	Form 10-Q (filed 2017-11-07) ↗
Q2 2017	Jun 30, 2017	1,600.00	-2.0%	Form 10-Q (filed 2017-08-07) ↗
Q1 2017	Mar 31, 2017	1,603.00	-1.4%	Form 10-Q (filed 2017-05-05) ↗
Q3 2016	Sep 30, 2016	1,640.00	-1.4%	Form 10-Q (filed 2016-11-07) ↗
Q2 2016	Jun 30, 2016	1,632.00	-0.1%	Form 10-Q (filed 2016-08-05) ↗
Q1 2016	Mar 31, 2016	1,625.00	+1.1%	Form 10-Q (filed 2016-05-06) ↗
Q3 2015	Sep 30, 2015	1,664.00	+3.4%	Form 10-Q (filed 2015-11-06) ↗
Q2 2015	Jun 30, 2015	1,633.00	+1.6%	Form 10-Q (filed 2015-08-07) ↗
Q1 2015	Mar 31, 2015	1,608.00	-0.1%	Form 10-Q (filed 2015-05-08) ↗
Q3 2014	Sep 30, 2014	1,610.00	+0.3%	Form 10-Q (filed 2014-11-07) ↗
Q2 2014	Jun 30, 2014	1,608.00	-0.1%	Form 10-Q (filed 2014-08-07) ↗
Q1 2014	Mar 31, 2014	1,609.00	+0.2%	Form 10-Q (filed 2014-05-09) ↗
Q3 2013	Sep 30, 2013	1,605.00	+1.8%	Form 10-Q (filed 2013-11-12) ↗
Q2 2013	Jun 30, 2013	1,609.00	+2.0%	Form 10-Q (filed 2013-08-09) ↗
Q1 2013	Mar 31, 2013	1,605.00	+1.8%	Form 10-Q (filed 2013-05-08) ↗
Q3 2012	Sep 30, 2012	1,577.00	–	Form 10-Q (filed 2013-11-12) ↗
Q2 2012	Jun 30, 2012	1,577.00	–	Form 10-Q (filed 2013-08-09) ↗
Q1 2012	Mar 31, 2012	1,577.00	–	Form 10-Q (filed 2013-05-08) ↗

Cite this data

StockData. (2026). AbbVie Weighted-average diluted shares outstanding (M), quarterly Q1 2012–Q2 2026 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/fs_sh_diluted

See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.